Stibbe assists in bespoke acquisition in media sector

Experience - Stibbe advises FL Entertainment, a global leader in independent content production and fastest-growing online sports betting platform in Europe through its Banijay Group and Betclic Everest Group businesses, on its business combination with Pegasus Entrepreneurial Acquisition Company Europe B.V. (Pegasus Entrepreneurs), a SPAC listed on Euronext Amsterdam, pursuant to which FL Entertainment will become a public company with an initial enterprise value of €7.2 billion  – the largest business combination by a European-listed SPAC.

Experience - On 22 April 2022, Amsterdam Trade Bank N.V. ("ATB") filed for bankruptcy and was declared bankrupt by the Amsterdam District Court. The court appointed A. van Hees and J.E.P.A. van Hooff as bankruptcy trustees.

Experience - Stibbe advises 3G Capital, the Brazilian-American leading investment firm with portfolio companies such as AB InBev, BurgerKing and KraftHeinz, on the acquisition of a controlling interest in Hunter Douglas, the global market leader in window coverings and a major manufacturer of architectural products with well-known products such as Luxaflex and Luxalon. The Sonnenberg family will continue to hold a 25% interest in Hunter Douglas, pro forma for the new capital structure.

Experience - Stibbe advises ID Logistics on the acquisition of GVT Transport & Logistics for an enterprise value of EUR 80 million.

Experience - Stibbe advises Azerion, a high-growth, profitable, digital entertainment and media company, on its business combination with European FinTech IPO Company 1 B.V. (EFIC1), a SPAC listed on Euronext Amsterdam, pursuant to which Azerion will become a public company with an initial enterprise value of €1.3 billion.

Experience - Stibbe advises Odyssey Acquisition on its EUR 1.5 billion business combination With BenevolentAI. The combination of Odyssey Acquisition S.A. (Odyssey), a Euronext Amsterdam-listed special-purpose acquisition company (SPAC) focused on European healthcare and TMT growth companies, and BenevolentAI, a leading clinical-stage AI drug discovery company, represents the largest European SPAC merger announced to date and one of the largest Euronext Amsterdam biotech listings ever.